IPCALAB
Ipcalab
Live Price
₹1,762.70
-8.50-0.48%
Conviction Scorecard
AI Momentum
90%Technical Rating
52%Analyst Sentiment
85%Market News & Buzz
📰
Recent news and updates for IPCALAB will appear here soon.
Stockmo Analyst Rationale
AI Generated Insight
"Robust technical setup for IPCALAB with strong AI conviction. The bullish trend in the healthcare space is accelerating while RSI at 52 suggests there is still significant room for upside before reaching overbought territory."
Verified by Stockmo Intelligence Grid
Supporting Evidence
Citing cross-referenced internal documents and market technicals
About Ipcalab
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetes, diabetology, emollients/protectives, fever, gastroenterology, haematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, regenerative, respiratory, rheumatology, and urology. The company also exports its products to Europe, Africa, the Americas, rest of Asia, the Commonwealth of Independent States, and Australasia. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Frequently asked questions
As of the latest market session, Ipcalab (IPCALAB) is trading at ₹1,762.7, representing a move of -0.48% from the previous close.
Ipcalab is listed and traded under the ticker symbol IPCALAB on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Ipcalab's stock price moved by -0.48%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 90% bullish probability for IPCALAB stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Ipcalab shares reached a high of ₹1,944.9 and hit a low of ₹1,251.6.
IPCALAB exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 79,184 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Ipcalab has a market capitalization of ₹44720.44 Cr, designating its size class inside the Healthcare sector.
Ipcalab has a current dividend yield of 34.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Ipcalab's trailing Price-to-Earnings (P/E) ratio is 39.21. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Ipcalab (IPCALAB) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Ipcalab's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore IPCALAB's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for IPCALAB are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Ipcalab operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.